UNSPSC 51401550: Triazolam

This classification denotes a benzodiazepine with the molecular formula C17H12Cl2N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1HM943223R, chemically known as 8-chloro-6-(o-chlorophenyl)-1-methyl-4h-s-triazolo(4,3-a)(1,4)benzodiazepine but generally known as triazolam, which bears US NIH Compound Identifier 5556. European Medicines Agency schedules Triazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11258MIG.

UNSPSC 51401550 Triazolam is a Commodity code that in practice captures pharmaceutical procurement by state and local health authorities, though the recent opportunity on file shows a significant mismatch between the code's nominal scope and actual usage. Seminole County, Florida, which appears to be the primary recent buyer under this code identifier, posted an IFB in June 2026 for naloxone and drug deactivation systems — products unrelated to triazolam, a benzodiazepine sedative. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. Vendors were required to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs in their proposals, maintain workers' compensation and general liability insurance, and comply with E-Verify employment verification. The contract offered a two-year initial term with a one-year renewal option and a three-month probationary period permitting termination without cause.

The code shows minimal recent activity specific to triazolam procurement at the state and local level. The single opportunity on record reflects Seminole County's community health initiative driven partly by FEMA funding, which introduced federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act. The mismatch between the code's pharmaceutical classification and the actual naloxone-focused procurement suggests either a cataloging error in Seminole County's system or that this Commodity code is not actively used for its intended product category in current state and local solicitations. Vendors pursuing pharmaceutical or medical-supply opportunities with Florida counties should monitor whether Seminole County reissues similar health-initiative contracts and confirm code alignment with actual product scope before bid preparation.